Arazlo · DIN 02517868 · 0.045% w/w · Lot
Limited Use, Reason for Use code 636 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 636 required
Write on scriptReason for Use code 636 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 636
Reason for Use code 636
For the treatment of acne vulgaris.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Arazlo · DIN 02517868
Manufacturer: Bausch Health Canada Inc.; listing date 2022-10-31
Health Canada: Marketed since 2021-09-16 · brand ARAZLO · ATC D05AX05 TAZAROTENE · form Lotion · route Topical · ingredients TAZAROTENE 0.045 %/W/W · company Bausch health, canada inc. · schedule Prescription
Arazlo: Formulary list price $1.41 per unit (the source does not state the unit; exact figure $1.4051). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02517868)
Source record
DIN 02517868: Arazlo
Raw flags: sec12=Y, sec3=Y
Item: 849200008; group id 873; item number 2111; lccId 00362; manufacturer id BHC
Source form: Lot; strength: 0.045% w/w
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.4051; ministry $1.4051
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02517868
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100721
Shortage status: not checked (no credentials)